# Mammoth Biosciences

CRISPR诊断先驱（Jennifer Doudna联合创始人）——基于SHERLOCK的DETECTR平台用于超灵敏核酸检测；CRISPR/Cas12/Cas13技术已授权多家IVD合作伙伴。

Source: https://cn.bioecon.ru/companies/mammoth-biosciences/
Updated: 2026-06-19

- 国家: United States
- 营收: ~$20M
- 员工: ~100 emp

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 迄今募集$375M | https://mammoth.bio/about/ |
| 监管批准 | 2022年获得FDA紧急使用授权（Emergency Use Authorization），用于DETECTR BOOST SARS-CoV-2 Reagent Kit | https://www.businesswire.com/news/home/20220124005618/en/Mammoth-Biosciences-Receives-FDA-Emergency-Use-Authorization-for-First-CRISPR-based-High-Throughput-COVID-19-Test |
| 生产基地 | 密苏里州圣路易斯（生产合作伙伴工厂） | https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/clinical-testing-and-diagnostics-manufacturing/ivd-manufacturing/ivd-case-study-crispr-based-assay-from-mammoth-biosciences |
| 生产基地 | 阿布扎比(计划中的先进疗法生产设施) | http://drupal.prod.genomeweb.com/business-news/mammoth-biosciences-partner-m42-abu-dhabi-department-health-drug-development, https://m42.ae/media-resources/news/abu-dhabi-advances-gene-editing-therapies-targeting-rare-diseases-through-strategic-global-collaboration/, https://www.pharmamanufacturing.com/industry-news/news/55387015/m42-mammoth-biosciences-to-advance-gene-editing-therapy-production-in-abu-dhabi |
| 产能 | 高通量系统8小时班次内可处理1,500次检测 [中等置信度] | https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/clinical-testing-and-diagnostics-manufacturing/ivd-manufacturing/ivd-case-study-crispr-based-assay-from-mammoth-biosciences |
| 认证 | 检测在高复杂度CLIA认证实验室进行 [中等置信度] | https://www.businesswire.com/news/home/20220124005618/en/Mammoth-Biosciences-Receives-FDA-Emergency-Use-Authorization-for-First-CRISPR-based-High-Throughput-COVID-19-Test |

独立来源: businesswire.com, drupal.prod.genomeweb.com, m42.ae, pharmamanufacturing.com, sigmaaldrich.com

## 技术

- [CRISPR 诊断](https://cn.bioecon.ru/technology/crispr-diagnostics/)